Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 10394-40-8 | MDL No. : | MFCD08685462 |
Formula : | C9H10N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FARVSSLSGAIQMM-UHFFFAOYSA-N |
M.W : | 146.19 | Pubchem ID : | 14856790 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 45.96 |
TPSA : | 17.82 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.91 cm/s |
Log Po/w (iLOGP) : | 1.79 |
Log Po/w (XLOGP3) : | 1.8 |
Log Po/w (WLOGP) : | 1.88 |
Log Po/w (MLOGP) : | 1.63 |
Log Po/w (SILICOS-IT) : | 1.91 |
Consensus Log Po/w : | 1.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.49 |
Solubility : | 0.478 mg/ml ; 0.00327 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.79 |
Solubility : | 2.35 mg/ml ; 0.0161 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.84 |
Solubility : | 0.212 mg/ml ; 0.00145 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.23 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With palladium 10% on activated carbon; hydrogen; toluene-4-sulfonic acid In methanol at 20℃; for 5 h; | Step B: Preparation of 1 ,6-dimethyl- 1H-benzo [dlimidazole: N,5 -dimethyl-2- nitro-aniline (20.2 g, 122 mmol), trimethyl orthoformate (133 mL, 1216 mmol), 10percent palladium on carbon (6.47 g, 6.1 mmol) and p-toluenesulfonic acid monohydrate (2.31 g, 12.2 mmol) in methanol (240 mL) was placed under 1 atmosphere of hydrogen with balloon and stirred at ambient temperature for 5 hours. Catalyst was removed by filtration and washed with methanol (200 mL). The filtrate was concentrated under reduced pressure. The residue was treated withsaturated sodium bicarbonate (50 mL) and ethyl acetate (300 mL). The organic layer was separated, washed with brine, dried (sodium sulfate), filtered and concentrated under reduced pressure to give 1,6-dimethylbenzimidazole (17.7 g, quantitative) as solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | With formic acid In hydrogenchloride; water | STR43 A mixture of 6.60 g of 1-amino-4-methyl-2-(N-methylamino)benzene and a solution of 3.5 ml of formic acid in 50 ml of a 4N HCl was stirred at 100° C. for 3.5 hours. The reaction solution was concentrated under reduced pressure and water was added to the residue. After washing with ethyl acetate, the aqueous phase was rendered alkaline with aqueous potassium carbonate followed by extraction with chloroform. The chloroform layer was washed with saturated sodium chloride solution, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (40 g). Elution with ethyl acetate followed by recyrstallization from ethyl acetate-hexane gave 4.01 g (57percent) of 1,6-dimethylbenzimidazole. |
[ 181867-18-5 ]
(1-Methyl-1H-benzo[d]imidazol-6-yl)methanol
Similarity: 0.88
[ 26530-93-8 ]
1-Methyl-1H-benzo[d]imidazol-6-amine
Similarity: 0.87